
In an exclusive interaction with Moneycontrol, K Anand Kumar, Managing Director of IIL, told that the technology transfer process is well underway, and the company has the capabilities and expertise to manufacture inactivated viral vaccines at commercial scale and under biosafety containment.
from Moneycontrol Business News https://ift.tt/3aQhGJD
Comments
Post a Comment